MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 597725 | Name: Snf 8815

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Snf 8815 is a cholecystokinin-B (CCK-B) agonist.

Chemical Structure

Snf 8815
Snf 8815
CAS#154336-13-7

Theoretical Analysis

MedKoo Cat#: 597725

Name: Snf 8815

CAS#: 154336-13-7

Chemical Formula: C56H68N10O13

Exact Mass: 1088.4967

Molecular Weight: 1089.21

Elemental Analysis: C, 61.75; H, 6.29; N, 12.86; O, 19.10

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Snf 8815; Snf-8815; Snf8815; 28-Mephe-31-N-meile-cck (26-33);
IUPAC/Chemical Name
(3S,6S,9S,15R,18S,21S)-9-((1H-indol-3-yl)methyl)-21-amino-3-(((S)-1-amino-1-oxo-3-phenylpropan-2-yl)carbamoyl)-6-butyl-18-(4-hydroxybenzyl)-7-methyl-5,8,11,14,17,20-hexaoxo-15-((R)-1-phenylethyl)-4,7,10,13,16,19-hexaazatricosanedioic acid
InChi Key
VEJMMYDVUKVYEP-HYXUPHFQSA-N
InChi Code
1S/C56H68N10O13/c1-4-5-20-45(54(77)64-43(29-48(71)72)52(75)62-41(50(58)73)25-33-14-8-6-9-15-33)66(3)56(79)44(27-36-30-59-40-19-13-12-18-38(36)40)61-46(68)31-60-55(78)49(32(2)35-16-10-7-11-17-35)65-53(76)42(26-34-21-23-37(67)24-22-34)63-51(74)39(57)28-47(69)70/h6-19,21-24,30,32,39,41-45,49,59,67H,4-5,20,25-29,31,57H2,1-3H3,(H2,58,73)(H,60,78)(H,61,68)(H,62,75)(H,63,74)(H,64,77)(H,65,76)(H,69,70)(H,71,72)/t32-,39+,41+,42+,43+,44+,45+,49-/m1/s1
SMILES Code
N[C@H](C(N[C@@H](Cc1ccc(O)cc1)C(N[C@H]([C@H](C)c2ccccc2)C(NCC(N[C@@H](Cc3c4ccccc4[nH]c3)C(N(C)[C@@H](CCCC)C(N[C@@H](CC(O)=O)C(N[C@@H](Cc5ccccc5)C(N)=O)=O)=O)=O)=O)=O)=O)=O)CC(O)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 1,089.21 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Povoski SP, Zhou W, Longnecker DS, Jensen RT, Mantey SA, Bell RH Jr. Stimulation of in vivo pancreatic growth in the rat is mediated specifically by way of cholecystokinin-A receptors. Gastroenterology. 1994 Oct;107(4):1135-46. Review. PubMed PMID: 7523219. 2: Povoski SP, Zhou W, Longnecker DS, Roebuck BD, Bell RH Jr. Growth of azaserine-induced putative preneoplastic nodules in the rat pancreas is mediated specifically by way of cholecystokinin-A receptors. Ann N Y Acad Sci. 1994 Mar 23;713:439-41. PubMed PMID: 8018216. 3: Povoski SP, Zhou W, Longnecker DS, Roebuck BD, Bell RH Jr. Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors. Cancer Res. 1993 Sep 1;53(17):3925-9. PubMed PMID: 8358719.